Background: Prostate cancer (PCa) patients receiving androgen deprivation therapy (ADT) are prone to suffer a series of potential side effects, including metabolic change, declining physical strength and worsening fatigue. Recent studies found that the change of lifestyle interventions can help to alleviate some adverse reactions, but the results were controversial. Therefore, the aim of this review was to comprehensively evaluate the effects of these lifestyle interventions on the side effects on PCa patients who received ADT. Methods: We searched several electronic databases, including ScienceDirect, PubMed, Cochrane library, CNKI and Wanfang database, without language restrictions. Among the literature, such lifestyle interventions as dietary advice, exercise and physical activities were carried out in the way of randomized controlled trials (RCTs) on PCa patients taking ADT. Pooled estimates were performed using fixed-effects or random-effects model. Results: Eleven RCTs involving 905 participants were included in this review. Compared with usual care group, exercise intervention could significantly improve the quality of life (QoL) of PCa patients undergoing ADT (P = 0.05, SMD = 0.17, 95% CI −0.00 to 0.34), but exercise plus dietary advice could not significantly improve the QoL (P = 0.15, SMD = 0.45, 95% CI −0.17 to 1.08). Moreover, lifestyle intervention could significantly change body composition (P = 0.03, SMD = −0.1, 95% CI −0.19 to −0.01). However, there showed no obvious difference in mitigating fatigue and depression (P = 0.46, SMD = 0.11, 95% CI −0.18 to 0.39; P = 0.31, SMD = −0.18, 95% CI −0.54 to 0.17).
Introduction
Prostate cancer (PCa) is the second most common malignancy in males after lung cancer, accounting for 21% of new cancer cases in the world (1) . The latest cancer statistics from the American Cancer Society in 2017 showed that the incidence of new PCa cases dropped by 2% (2) . Though the disease poses major health threat to men, its etiology is still under investigation. According to the report, Australia, New Zealand, Northern America and Europe posted higher incidence rates than any other regions in the world (3) , with the 5 year survival rates in some countries approaching 100% (4, 5) . Currently, androgen deprivation therapy (ADT) as the first line therapy for PCa, has been widely used in men with advanced or metastatic PCa. However, several side effects, including worsening fatigue and depression (6) , increasing fat mass (7) , falling physical function and quality of life (QoL) (8, 9) , followed the steps of ADT. These side effects also increased the risk of cardiovascular morbidity and erectile dysfunction, increasing medical cost and lowering the life quality of PCa patients undergoing ADT (10, 11) .
ADT, a common endocrine therapy for PCa, had been put into clinical application for quite a long time. The current agents of ADT in PCa include androgen biosynthesis inhibitors (ketoconazole, abiraterone, Tak-700 and Tok-001) and androgen receptor (AR) inhibitors (bicalutamide, enzalutamide, MDV3100 and ARN509) (12) . The former could suppress testicular androgen biosynthesis and led to disease remissions, the later could inhibit the functions of the androgen receptors (AR), exerted antagonistic effects (13) . The main molecular basis of ADT therapy include selective inhibit the activation of CYP17 enzyme, or suppress androgen-bound AR translocation to the nucleus, and block AR DNA binding, regulate gene transcription and PCa cells functions (14, 15) .
Current evidence indicated that lifestyle factors (diet, exercise, physical activity and smoking) could increase the risks of cancers, so identifying the risk factors that cause cancers and are able to take measures to prevent them. Healthy lifestyle recommendations from doctors can motivate the patients to adopt beneficial behavior changes to improve QoL (16) . Rocket et al. (17) summarized that for long-term cancer survivors, healthy diet and physically active lifestyle, weight management, stress and sleeping assessment should be the priorities for PCa patients. Besides, they also discussed selected nutrition, physical activity, cancer sites and common questions to help cancer survivors prolong life and live better. Therefore, lifestyle interventions promoting healthy diet and exercise behaviors have been recommended as crucial methods to counteract the side effects, and have the potential to reduce morbidity and mortality in the treatment of cancer (18) .
In prostate cancer, improper post-diagnostic dietary pattern was related to higher PCa specificity and mortality, while healthy dietary pattern reduced prostate cancer specificity and lowered mortality (19) . As the treatment with ADT extends to longer term, the side effects get worse. While some other studies proved that lifestyle changes and adequate physical activity can be adopted to alleviate these reactions. Moyad et al. (20) indicated that proper diet, exercise and nutritional supplementation could be a convenient and costeffective way to alleviate ADT-related toxicities without causing additional adverse effects.
Previous reviews or meta-analysis have clarified that exercise or physical activity may be benefit to reduce the side effect of ADT in PCa patients. However, some studies only described the role of life intervention on PCa patients, and insufficient data will also not be able to draw a rational conclusion. Therefore, the purpose of our study was to comprehensively evaluate the effects of these lifestyle interventions on alleviating the adverse effects on prostate cancer patients who received ADT.
Material and methods

Search strategy
We searched the electronic databases of ScienceDirect, PubMed, Embase, Cochrane library, Chinese National Knowledge Infrastructure (CNKI) and Wanfang database without language restrictions. Published studies were collected from the inception of these databases. The search terms included 'lifestyle interventions' or 'dietary advice' or 'exercise' or 'physical activity' and 'androgen deprivation therapy' and 'prostate cancer', and the deadline was defined as 31 October 2017.
Selection criteria
Inclusion criteria are as follows. (1) All participants were adult men and the diagnoses were based on pathology reports and staging studies. (2) The participants all underwent ADT for at least 3 months. (3) Lifestyle interventions contain dietary advices, aerobic and resistance exercises, and physical activity. (4) The patients had minimum lifestyle intervention duration of 6 weeks and availability of a full text publication. Exclusion criteria: Men with diabetes, uncontrolled hypertension, cardiovascular disease and unstable bony metastases were excluded.
Data extraction
Two review investigators (MF Ying and MX Li) independently extracted data from each study following standardized data extraction requirements. According to the inclusion criteria, extracted data should include the baseline characteristics of participants, study design, intervention type and comparator. The outcomes include QoL, fatigue, body composition and depression.
Quality assessment
We assessed the methodological quality of all included studies using the Cochrane risk of bias tool. Each study was graded low quality or high quality according to assessment outcomes. Any discrepancies during the process of data extraction and quality assessment were resolved by discussion or consulting the original article until consensus was reached.
Data analysis
As to the outcomes of this meta-analysis, Review Manager 5.3 software was used for statistical analysis. For continuous data, the outcomes were expressed as standardized mean difference (SMD) with 95% CIs. When pooling was taken, the heterogeneity was evaluated by using the I 2 statistic. Significant difference for heterogeneity was considered when P < 0.05, and substantial heterogeneity represented when I 2 value was no less than 50%. Fixed effect and random effect models were used, respectively, to test homogeneity and significant heterogeneity data. All included studies were evaluated the risk of bias, and sensitivity analysis was conducted by excluding the mixed studies which might yield biased results in the end. A P values less than 0.05 was considered to be statistically significant.
Results
Description of the studies
At first, 2019 papers were sifted out after searching the electronic databases. Among the papers, 1979 were ruled out after scrutinizing the titles and abstracts, 40 full-text articles were obtained to do eligibility assess, then 11 articles met the inclusion criteria and were selected for our review (21-31) (Fig. 1 ). The characteristics of the included studies are summarized in Table 1 . A total of 905 participants were included in this meta-analysis, with 480 in the intervention group and 425 in the usual care control group. The participants ranged from 66 to 73 years old. Seven studies involved aerobic and resistance exercise, while the remaining four studies engaged in exercise and dietary intervention. All intervention trials were completed under supervision, and the PCa survivors received ADT for at least 3 months. The results of Jadad quality scores showed that seven studies were of good quality, while the other four studies were scored no more than 4. All RCTs were assessed in terms of the risk of bias; the results indicated that all studies exhibited low risk of bias. Meanwhile, Fig. 2 shows that the funnel shape is not perfectly symmetrical, suggesting that potential publish bias exists.
Quality of life (QoL)
QoL is an important evaluation indicator for cancer survivors. Health-related QoL and disease-specific QoL were measured by the MOS 36-Item Short-Form Health Survey (SF-36) and the Functional Assessment of Cancer Therapy-Prostate (FACT-P) scale (32, 33) . Nine studies involving 740 participants assessed QoL improvement after lifestyle interventions in PCa patients. Three of these studies performed excise plus diet intervention, the other six articles only used exercise intervention. As shown in Fig. 3A , fixed effect model was used to assess the outcomes because no significant heterogeneity was observed between the two groups (P = 0.81, I 2 = 0%). Compared with usual care group, exercise intervention could significantly improve the QoL of PCa patients undergoing ADT (P = 0.05, SMD = 0.17, 95% CI −0.00 to 0.34). Meanwhile, random effect model was used to assess the exercise plus dietary advice because significant heterogeneity was observed (P = 0.006, I 2 = 80%). The result suggested that exercise plus dietary advice could not significantly improve the QoL (P = 0.15, SMD = 0.45, 95% CI −0.17 to 1.08) (Fig. 3B ). Health-related QoL and general QoL were reported in both exercise and dietary intervention studies. Among the nine studies, two of them were about general QoL, only one was about health-related QoL. There indicated no significant statistical heterogeneity (P = 0.49, I 2 = 0%). Moreover, there was no difference between lifestyle intervention group and usual care group in improving the generalQoL for PCa patients treated with ADT (P = 0.45, SMD = 0.12, 95% CI −0.19 to 0.44). 
Fatigue and depression
Nine studies involving a total of 737 participants evaluated the intervention effects on fatigue. Random effect model was used because significant heterogeneity was observed (P < 0.0001, I 2 = 74%). The results showed that no significant difference between the two groups, exercise and diet intervention did not alleviate the fatigue of PCa patients (P = 0.46, SMD = 0.11, 95% CI −0.18 to 0.39) (Fig. 4A) . Only two trials with 124 patients assessed the intervention effects on depression, we found that aerobic and resistance exercise could not significantly mitigate depression of PCa survivors (P = 0.31, SMD = −0.18, 95% CI −0.54 to 0.17) (Fig. 4B) .
Body composition
The intervention effects on body composition were analyzed by assessing lean body mass, fat mass, percentage fat mass and body weight in this study. As shown in Fig. 5 , we performed subgroup analysis for body composition. Five lifestyle intervention studies with 292 participants assessed the effects of exercise and diet intervention on lean body mass. Fixed effect model was used as there was no significant heterogeneity (P = 0.55, I 2 = 0%). Compared with usual care group, exercise and diet intervention could not significantly increase the lean body mass (P = 0.91, SMD = −0.01, 95% CI −0.24 to 0.22). Five lifestyle intervention studies involving a total of 322 PCa survivors evaluated fat mass and 393 PCa survivors evaluated percentage fat mass. Quantitative analysis showed that exercise and diet intervention did not significantly lower fat mass (P = 0.12, SMD = −0.17, 95% CI −0.39 to 0.04). Lifestyle intervention could significantly reduce the percentage fat mass (P = 0.03, SMD = −0.21, 95% CI −0.4 to 0.03). Besides, six intervention studies assessed body weight and BMI, respectively. We found that lifestyle intervention could not obviously reduce body weight and lower BMI (P = 0.86, SMD = 0.02, 95% CI −0.17 to 0.2; P = 0.3, SMD = −0.11, 95% CI −0.32 to 0.1). Overall, the results suggested that lifestyle intervention could significantly change the body composition of PCa patients treated with ADT (P = 0.03, SMD = −0.1, 95% CI −0.19 to −0.01).
Sensitivity analysis
We performed a sensitivity analysis by the method of combined data (random effect or fixed effect model). The values of SMD were similar between fixed effect model and random effect model, and the overall effect also showed similarity. Moreover, in an attempt to identify the factors resulting in heterogeneity, a sensitivity analysis was conducted by excluding the mixed and published bias studies, and no significant difference was observed. These data were not shown.
Discussion
In the paper, we systematically developed into the effects of lifestyle interventions on the treatment-related adverse effects of ADT. Eleven RCTs were included in our study, and we assessed the changes in QoL, fatigue, depression and body composition. The evidences suggested that exercise and diet intervention were better beneficial to improving the QoL and changing the body composition, but had only minor effects in mitigating the fatigue and depression.
Lifestyle interventions have proved to have beneficial effects on the QoL of patients with cancers. In the study of Chipperfield et al. (34) , preliminary data indicated that physical activity could improve QoL in PCa patients receiving ADT. Moreover, Teleni et al. (35) investigated the effects of exercise on QoL of PCa patients treated with ADT. The results indicated that PCa patients receiving ADT secured health improvement and higher disease specific life quality after 12-24 weeks of aerobic and resistance exercise. In our study, nine trials were included and the results showed that exercise intervention could significantly improve QoL in men with PCa undergoing ADT, but exercise plus dietary advice could not significantly improve the QoL. However, in the RCTs of Bourke and Neill, they all confirmed that exercise plus dietary advice could significantly improve the QoL of PCa receiving ADT. The result was inconsistent, and this might be related to the number of included studies. Therefore, we concluded that exercise intervention could better improve QoL in men with PCa undergoing ADT.
Many studies found that ADT has been associated with metabolic syndrome and cardiovascular disease (CVD), fatigue, depression and cognitive deficits. PCa patients undergoing ADT have higher risks of skeletal fracture, osteoporosis, and decreasing lean body mass and increasing fat mass, but androgen supplementation could alleviate these complications (36) . Keating et al. found that the use of ADT in the treatment of PCa could increase risks of incident diabetes, incident coronary heart disease, myocardial infarction, sudden cardiac death and stroke (37) . O'Farrell et al. (38) evaluated the association between risk of CVD and the duration in men with PCa undergoing ADT, the results showed that CVD risk was increased during the first 6 months. Other negative side effect of ADT therapy was cognitive impairment. A systematic review and meta-analysis showed that the visuomotor functions of PCa patients were worse, and led to the deficit of cognitive functioning (39) . Moreover, Castoria et al. (40) found that extra-nuclear AR played a key role in regulating neuronal differentiation and neurodegenerative disorders. Nead et al. (41) found that the use of ADT in the treatment of PCa increased the risk of Alzheimer's disease. Therefore, the future therapeutic strategies should to improve the side effects on central nervous system, metabolic syndrome and cardiovascular disease for PCa patients undergoing ADT.
Body composition is one of the factors influencing pharmacokinetics and can be changed by certain chemotherapy regimens (42) . Although ADT could reduce PCa-specific mortality, it could also increase metabolic parameter and change body composition, leading to metabolic syndrome. The impact of ADT on body composition was evaluated by measuring lean body mass, fat mass, percentage fat mass, body weight and BMI in PCa patients. Londen et al. (43) found that men with PCa undergoing over 2 years of ADT would see sharp increase in fat mass and significant decline in lean body mass. Moreover, Kim et al. (44) indicated that PCa patients receiving ADT witnessed average weight gain in the first year of treatment, but weight change vanished in the following treating cycles.
Several studies demonstrated that exercise could markedly changed body composition in men treated with ADT. In the clinical trial of Kerri et al. (45) , they found that one-year resistant and impact exercises could reduce body fat and exert an insulin-lowering effect. However, segal et al. (30) proved that 12-weeks resistance exercise intervention could not change body composition. A systematic review indicated that exercise often could improve body composition, muscle mass and physical function in men receiving ADT (46) . Likewise, our retrospective study indicated that 12-24 weeks of exercise and diet intervention could also significantly reduce the body composition of PCa patients. But the effects of lifestyle intervention on increasing lean body mass, reducing body weight and BMI were slight, so additional well-designed RCTs were needed to further evaluate these indicators. Besides, diet is an important part of weight management, so more studies should integrate diet with exercise intervention in future researches.
Fatigue is a common symptom for men with PCa undergoing ADT, and it has been reported that over 43% PCa patients treated with ADT experienced serious fatigue (47) . Early studies found that fatigue severity scale scores would surge in men with PCa after 3 months of treatment with hormone therapy (48) . Later, Nelson et al. (49) demonstrated that the symptom of fatigue would worsen in PCa patients receiving ADT during the first 12 months. In our study, we evaluated the effects of lifestyle interventions on fatigue in men undergoing ADT; the results found that lifestyle changes could not significantly mitigate the fatigue, depression and blood pressure issue. For fatigue, we included nine trials to evaluate the intervention effects on these side effects. Among these studies, six RCTs showed that lifestyle interventions were more effective in alleviating fatigue than usual care group, but the others showed no significant difference. Two RCTs were conducted to assess the intervention effects on depression, no significant difference was observed between intervention group and usual care group. However, a systematic metaanalysis of exercise on treatment-related adverse effect of ADT established that exercise training could be effective in mitigating ADT induced fatigue (50) . This result is contrary to our study. A potential explanation for this finding is that only four studies were included to assess treatment-related fatigue in the study of Gardner, resulting in certain deviations.
However, a number of limitations should be taken into account when interpreting the results in this review. Firstly, the number of included studies was small, and the included trials were of moderate quality, both of which may prove to be inadequate to draw the most reliable conclusions. Secondly, substantial heterogeneity was observed in this systematic review, so we could only come to restricted conclusions. Last but not least, studies published in protocol form did not represent data that could be included to analyze the outcomes in this review. Given these limitations, additional large scale RCTs with higher quality are necessary to evaluate the effects of lifestyle interventions on PCa patients undergoing ADT. Furthermore, more dietary intervention studies should be included to assess the intervention effects on QoL, fatigue and body composition in men receiving ADT.
Conclusion
To sum up, the results of this systematic review indicated that exercise interventions could better improves the QoL and change the body composition of PCa patients treated with ADT. However, the combination of resistance exercise and diet intervention showed little effects in mitigating the fatigue and depression for treatmentrelated adverse effects in men with PCa receiving ADT. Currently, many preclinical and clinical studies found that lifestyle modification (includes diet control, physical activity, smoking and alcohol cessation) and the supplements of vitamins and minerals were benefit in improving these side effects of ADT. Meanwhile, other new antagonists and small molecules peptides have been applied to enhance AR degradation and regulate genomic or no-genomic transcription, inhibiting the progression of PCa, and avoid the side effects of ADT in the treatment of PCa. Therefore, we should profoundly exploit the mechanism of AR action in PCa to develop new target drugs. Moreover, more clinical research protocol should be established in the future study, so that better therapeutic regimens for PCa patients are likely to emerge in the process.
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